Produkty 147411-69-6

CAS 147411-69-6 występuje w naszej ofercie pod nazwami: Pyriminobac-methyl-E/Z mixture at oxime, (E)-Pyriminobac-methyl, (E)-Pyriminobac-methyl 10 µg/mL in Cyclohexane, Pyriminobac-methyl-E/Z mixture at oxime, 95%, 95%, (E)-Pyriminobac-methyl, Concentration: 100 µg/ml Solvent: Acetonitrile. Oferty producentów: TRC, Dr. Ehrenstorfer, Chemat, HPC Standards. Dostępne opakowania: 500mg, 10mg, 10ml, 1x5ml, 1x10mg.

Pyriminobac-methyl-E/Z mixture at oxime
TRC
  • opakowanie: 500mg
  • Warianty: 1
Zobacz produkt
(E)-Pyriminobac-methyl
Dr. Ehrenstorfer, HPC Standards
  • opakowanie: 10mg, 1x10mg
  • Warianty: 2
od 755,42
Zobacz produkt
(E)-Pyriminobac-methyl 10 µg/mL in Cyclohexane
Dr. Ehrenstorfer
  • opakowanie: 10ml
  • Warianty: 1
Zobacz produkt
Pyriminobac-methyl-E/Z mixture at oxime, 95%, 95%
Chemat
  • opakowanie: 10mg
  • Warianty: 1
od 237,20
Zobacz produkt
(E)-Pyriminobac-methyl, Concentration: 100 µg/ml Solvent: Acetonitrile
HPC Standards
  • opakowanie: 1x5ml
  • Warianty: 1
od 649,64
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

Methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate (CAS 147411-69-6) to związek chemiczny o wzorze sumarycznym C17H19N3O6 i masie molowej 361.3 g/mol. Nazwa systematyczna IUPAC: methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate. InChIKey: USSIUIGPBLPCDF-KEBDBYFISA-N.

Dane identyfikacyjne
Wzór sumarycznyC17H19N3O6
Masa molowa361.3 g/mol
Nazwa IUPACmethyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate
InChIKeyUSSIUIGPBLPCDF-KEBDBYFISA-N
SMILESC/C(=N\OC)/C1=C(C(=CC=C1)OC2=NC(=CC(=N2)OC)OC)C(=O)OC

Dane obliczone przez PubChem (NCBI)

Synonimy: Pyriminobac-methyl, (E)-PYRIMINOBAC-METHYL, E-Pyriminobac-methyl, Pyriminobac-methyl [ISO], Pyriminobac-methyl [ISO:BSI], Pyriminobac-methyl-E/Z mixture at oxime, Pyriminobac-methyl (E), HIECLEAN, Pyriminobac-methyl, BSI, PYRIMINOBAC METHYL ESTER
Powiązane formy tego związku
methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate C17H19N3O6
methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(Z)-N-methoxy-C-methylcarbonimidoyl]benzoate C17H19N3O6
Izomery (ten sam wzór sumaryczny)
N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
[(2S,3S,4R,5R)-3-amino-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-2-yl]methyl 4-methylbenzoate C17H19N3O6
[(4S)-2-[6-[(4S)-4-(acetyloxymethyl)-4,5-dihydro-1,3-oxazol-2-yl]-2-pyridinyl]-4,5-dihydro-1,3-oxazol-4-yl]methyl acetate C17H19N3O6
N-[1-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
methyl 5-hydroxy-6-oxo-2-[2-(phenylmethoxycarbonylamino)propan-2-yl]-1H-pyrimidine-4-carboxylate C17H19N3O6
N-[1-[(4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]-4-methoxybenzamide C17H19N3O6
(2R,3R)-2,3-dihydroxybutanedioic acid;(1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene C17H19N3O6